PPARG and Alzheimer disease: As demonstrated in volunteers with DM2 (Sato et al., 2011) as well as in mouse models of AD (Nicolakakis et al., 2008; Papadopoulos et al., 2013), PPARγ agonists promote central glucose metabolism.